Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US…
Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle…